Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 601–700 of 995
The amyloid cascade hypothesis and Alzheimer’s disease: A mathematical model
Bertsch, M., Franchi, B., Meacci, L., Primicerio, M., & Tesi, M. C. (2020) · European Journal of Applied Mathematics · doi:10.1017/s0956792520000339 · Cited by 28
Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J., & Yahaya, M. F. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1292858 · Cited by 28
Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging
Patel, V., Zhang, X., Tautiva, N., Nyabera, A., Owa, O., Baidya, M., Sung, H., Taunk, P., Abdollahi, S., Charles, S., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150504145646 · Cited by 25
Phosphorylated tau in neuritic plaques of APPsw/Tauvlw transgenic mice and Alzheimer disease
Pérez, M., Morán, M. A., Ferrer, I., Ávila, J., & Gómez‐Ramos, P. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0420-0 · Cited by 26
“transgenic mice, in vivo multiphoton microscopy has shown that plaques appear in a short time (24 h) and are followed in a few days by the appearance of dystrophic neurites [29].”
BackgroundRozkalne, A., Spires-Jones, T. L., Stern, E. A., & Hyman, B. T. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.045 · Cited by 25
Self-citationSpires-Jones, T. L., Calignon, A. D., Meyer-Luehmann, M., Bacskai, B. J., & Hyman, B. T. (2011) · Methods · doi:10.1016/j.ymeth.2010.12.009 · Cited by 24
Self-citationFörster, C. Y., Shityakov, S., Scheper, V., & Lenarz, T. (2022) · Biomolecules · doi:10.3390/biom12111717 · Cited by 32
β-amyloid and glutamate receptors
Gasparini, L., & Dityatev, A. E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.005 · Cited by 29
Suh, E. C., Jung, Y. J., Kim, Y. A., Park, E.-M., Lee, S. J., & Lee, K. E. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.007 · Cited by 24
Więckowska, A., Bajda, M., Szałaj, N., & Malawska, B. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.010 · Cited by 24
Murakami, K., Yokoyama, S.-I., Murata, N., Ozawa, Y., Irie, K., Shirasawa, T., & Shimizu, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.101 · Cited by 26
Stanciu, S. G., Tranca, D. E., Hristu, R., & Stanciu, G. A. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.005374 · Cited by 24
Shin, N. N., Jeon, H., Jung, Y., Baek, S., Lee, S., Yoo, H. C., Bae, G. H., Park, K., Yang, S.-H., Han, J. M., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00093 · Cited by 28
Bertsch, M., Franchi, B., Meschini, V., Tesi, M. C., & Tosin, A. (2020) · Brain Multiphysics · doi:10.1016/j.brain.2020.100020 · Cited by 26
“, rapid) s-scale, where the unit time coincides with hours, for the diffusion and agglomeration of Aβ [35]; and a long (i.”
BackgroundCannabinoids and Neurodegenerative Diseases
Romero, J., & Martínez-Orgado, J. A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824589 · Cited by 28
Woods, J. J., Skelding, K. A., Martin, K. L., Aryal, R., Sontag, E., Johnstone, D. M., Horvat, J. C., Hansbro, P. M., & Milward, E. A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.10.014 · Cited by 26
Microglia in Alzheimer’s Disease
Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 28
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
Perea, J. R., Bolós, M., Cuadros, R., García, E., García‐Escudero, V., Hernández, F., McManus, R. M., Heneka, M. T., & Ávila, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02715-0 · Cited by 24
Imaging microcircuit function in healthy and diseased brain
Garaschuk, O. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.009 · Cited by 24
Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice
Cohen, A. D., Ikonomović, M. D., Abrahamson, E. E., Paljug, W. R., DeKosky, S. T., Lefterov, I. M., Koldamova, R. P., Shao, L., Debnath, M., Mason, N. S., et al. (2009) · Letters in Drug Design & Discovery · doi:10.2174/157018009789057526 · Cited by 23
Amyloid Features and Neuronal Toxicity of Mature Prion Fibrils Are Highly Sensitive to High Pressure
Moustaine, D. E., Perrier, V., Ba, I. A.-T. V., Meersman, F., Ostapchenko, V. G., Baskakov, I. V., Lange, R., & Torrent, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192872 · Cited by 25
Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 24
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
Croft, C. L., Goodwin, M. S., Ryu, D. H., Lessard, C. B., Tejeda, G., Marrero, M., Vause, A. R., Paterno, G., Cruz, P. E., Lewis, J. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02264-9 · Cited by 27
“This rapid formation of tau inclusions in BSCs is reminiscent of the formation of β-amyloid plaques observed in vivo [42] and on a timescale of tau inclusion formation in vivo in tau transgenic mice [18].”
BackgroundKong, W., Mou, X., Zhang, N., Zeng, W., Li, S., & Yang, Y. (2015) · BioMed Research International · doi:10.1155/2015/394260 · Cited by 25
“The pathomorphism features of AD are the senile plaques (SP) and neurofibrillary tangles (NFT), cerebrovascular amyloid, dystrophic neuritis, and loss of synaptic connections [1, 2].”
BackgroundMilanović, D., Petrović, S., Brkić, M., Avramović, V., Perović, M., Ivković, S., Glibetić, M., & Kanazir, S. (2018) · Nutrients · doi:10.3390/nu10091250 · Cited by 29
“When a certain critical concentration of Aβ oligomeric form is achieved, plaques form quickly and grow to a mature, stable size within days and that short period may be the time-frame for glial action [56].”
BackgroundVerkhratsky, A., Zorec, R., Rodriguez, J. J., & Parpura, V. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_17 · Cited by 24
Björk, L., Klingstedt, T., & Nilsson, K. P. R. (2023) · ChemBioChem · doi:10.1002/cbic.202300044 · Cited by 28
The role of A$$\beta $$ and Tau proteins in Alzheimer’s disease: a mathematical model on graphs
Bertsch, M., Franchi, B., Tesi, M. C., & Tora, V. (2023) · Journal of Mathematical Biology · doi:10.1007/s00285-023-01985-7 · Cited by 27
Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease
Kozin, S. A., Kechko, O. I., Adzhubei, A. A., Makarov, A. А., & Mitkevich, V. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010072 · Cited by 32
Haka, A. S., Potteaux, S., Fraser, H., Randolph, G. J., & Maxfield, F. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044823 · Cited by 24
“Although multiphoton microscopy is amenable to intravital imaging, it is usually limited to biological tissues that can be isolated from the anesthetized mouse or easily stabilized [21,22,23,24].”
BackgroundMitew, S., Kirkcaldie, M., Dickson, T. C., & Vickers, J. C. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00030 · Cited by 24
von Saucken, V. E., Jay, T. R., & Landreth, G. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105072 · Cited by 23
“It is well described that plaques readily recruit microglia and that plaque-associated microglia preferentially orient their processes to contact plaques (Meyer-Luehmann et al., 2008).”
Chapter 8 The Molecular and Cellular Pathogenesis of Dementia of the Alzheimer's Type
Luque, F. A., & Jaffe, S. L. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00408-5 · Cited by 24
Regulation of Macrophage and Dendritic Cell Responses by Their Lineage Precursors
Cortez‐Retamozo, V., Etzrodt, M., & Pittet, M. J. (2012) · Journal of Innate Immunity · doi:10.1159/000335733 · Cited by 24
“They scavenge the central nervous system for damaged neurons and infectious agents; however, they are also associated with the pathogenesis of severe neurodegenerative diseases [68, 69].”
BackgroundOligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
Gericke, C., Mallone, A., Engelhardt, B., Nitsch, R. M., & Ferretti, M. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01029 · Cited by 22
“Microglia migrate toward beta-amyloid plaques (4), surround them and initiate inflammasome activation (5), secretion of pro-inflammatory cytokines (6, 7) as well as upregulation of phagocytosis and antigen presentation-related genes (8).”
BackgroundQuan, W., Luo, Q., Hao, W., Tomic, I., Furihata, T., Schulz‐Schaeffer, W., Menger, M. D., Fassbender, K. C., & Liu, Y. (2021) · Glia · doi:10.1002/glia.24007 · Cited by 20
“…which overexpress Alzheimer's amyloid precursor protein (APP) in neurons, microglia are activated and recruited to Aβ deposits (Bolmont et al., 2008; Meyer-Luehmann et al., 2008), and are more closely correlated with the impairment of cognitive performance than Aβ deposition (Focke et al., 2018).”
BackgroundMarković, M., Milošević, J. R., Wang, W., & Cao, Y. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000726 · Cited by 25
Gottlieb, C. D., Thompson, A. C. S., Ordureau, A., Harper, J. W., & Kopito, R. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009654 · Cited by 23
Stoyanov, S., Sun, W., Düsedau, H. P., Cangalaya, C., Choi, I., Mirzapourdelavar, H., Baidoe‐Ansah, D., Kaushik, R., Neumann, J. H. L., Dunay, I. R., et al. (2020) · Glia · doi:10.1002/glia.23894 · Cited by 25
“The microglial envelopment of protofibrillar Aβ plaques and collateral neurotoxicity expand with age (Bolmont et al., 2008; Condello, Yuan, Schain, & Grutzendler, 2015; Meyer-Luehmann et al., 2008).”
BackgroundExploring the link between dystrophic microglia and the spread of Alzheimer's neuropathology
Shahidehpour, R. K., Nelson, P. T., Katsumata, Y., & Bachstetter, A. D. (2024) · Brain · doi:10.1093/brain/awae258 · Cited by 23
Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric p -Phenylene Ethynylenes
Fanni, A. M., Okoye, D., Monge, F. A., Hammond, J., Maghsoodi, F., Martin, T. D., Brinkley, G., Phipps, M. L., Evans, D. G., Martinez, J. S., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c22869 · Cited by 21
Kelley, C. M., Perez, S. E., Overk, C., Wynick, D., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102097 · Cited by 21
“Using in vivo microscopy in young (5, 6-month) A PPswe/PS1 E9 mice, plaque formation was shown to be a rapid but rare event, with no change in plaque size occurring after the first 24 hours of appearance [52].”
Detecting Amyloid-β Plaques in Alzheimer’s Disease
Baltes, C., Princz-Kranz, F. L., Rudin, M., & Mueggler, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-61737-992-5_26 · Cited by 23
Reprint of: Microglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 21
Masliah, E. (2008) · Nature · doi:10.1038/451638a · Cited by 21
Imbalance in the response of pre- and post-synaptic components to amyloidopathy
Stephen, T., Tamagnini, F., Piegsa, J., Sung, K., Harvey, J., Oliver‐Evans, A., Murray, T. K., Ahmed, Z., Hutton, M. L., Randall, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50781-1 · Cited by 25
Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
Nury, T., Lizard, G., & Véjux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072501 · Cited by 23
“, which coincided with the arrival of microglial cells, while plaque resolution was not observed for weeks [57,58].”
BackgroundPresenilins, Deranged Calcium Homeostasis, Synaptic Loss and Dysfunction in Alzheimer's Disease
Александровна, П. Е., Supnet, C. B., & Борисович, Б. И. (2012) · Messenger · doi:10.1166/msr.2012.1002 · Cited by 21
“It has been demonstrated that dendrites surrounding amyloid plaques in the brain of APPswe/PS1delta9xYFP (B6C3-YFP) transgenic mice showed abnormal curvature and dystrophic swelling (Meyer-Luehmann et al., 2008).”
BackgroundFunctional Brain Imaging: A Comprehensive SurveyPreprint
Sarraf, S., & Sun, J. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1602.02225 · Cited by 20
Health Policies and Black Americans
Willis, D. P. (1988) · DigitalGeorgetown (Georgetown University Library) · Cited by 22
The endocannabinoid system and amyloid-related diseases
Ruiz‐Valdepeñas, L., Benito, C., Tolón, R. M., Martínez-Orgado, J. A., & Romero, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.024 · Cited by 22
“…suggest that the kinetics of amyloid deposition may be subjected to acute changes that could accelerate the process and reinforce the “amyloid hypothesis”, as peptide deposition preceded other events such as microglia recruitment and activation or neuronal alterations (Meyer-Luehmann et al., 2008).”
BackgroundInfluentialLinazasoro, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.011 · Cited by 19
Fibrillogenesis of Huntingtin and Other Glutamine Containing Proteins
Lyubchenko, Y. L., Krasnoslobodtsev, A. V., & Luca, S. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_10 · Cited by 19
“It was recently shown that the growth of amyloid plaques in vivo follows the same model (Meyer-Luehmann et al. 2008).”
BackgroundUchida, Y., Gomi, F., Murayama, S., & Takahashi, H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.014 · Cited by 21
Gschwind, T., Lafourcade, C., Gfeller, T., Zaichuk, M., Rambousek, L., Knuesel, I., & Fritschy, J. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13983 · Cited by 19
Tyrakis, P. A., Agridi, C., & Kourti, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168630 · Cited by 22
“Microglia and other cells attracted to the area may cause further plaque formation from the amorphous fragments of degenerated neuronal cells, subsequently releasing pro-inflammatory molecules and inducing oxidative stress [12,13].”
BackgroundAjit, D., Udan, M. L. D., Paranjape, G. S., & Nichols, M. R. (2009) · Biochemistry · doi:10.1021/bi9003777 · Cited by 20
“Imaging of the Aβ(1-42) aggregation solutions with atomic force microscopy indicated that best cellular response coincided with the appearance of fibrillar structures yet conditions that accelerated or increased Aβ(1-42) fibril formation such as peptide concentration, temperature, or reconstitution in NaOH/PBS at pH 7.”
InfluentialCurrent Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review
Chandrashekar, K. S., Mathew, A., Vignesh Balaji, E., Pai, K. S. R., Kishore, A., Pai, V., & Pemmireddy, R. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220401124719 · Cited by 20
The Convergence of Alzheimer’s Disease Pathogenesis Concepts
Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026893319060104 · Cited by 19
Vargas-Soria, M., Ramos‐Rodríguez, J. J., del Marco, À., Hierro‐Bujalance, C., Carranza-Naval, M. J., Calvo-Rodríguez, M., van Veluw, S. J., Stitt, A. W., Simó, R., Bacskai, B. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00380-6 · Cited by 25
Self-citationThe β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
Li, S. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15782 · Cited by 19
A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease
Harenbrock, J., Holling, H., Reid, G., & Koychev, I. G. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100068 · Cited by 25
Wu, J., Li, Y., Tian, S., Na, S., Wei, H., Wu, Y., Yang, Y., Shen, Z., Ding, J., Bao, S., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14633 · Cited by 19
Chaves, E. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-076 · Cited by 19
Microscopic and macroscopic models for the onset and progression of Alzheimer's disease
Bertsch, M., Franchi, B., Tesi, M. C., & Tosin, A. (2017) · Journal of Physics A Mathematical and Theoretical · doi:10.1088/1751-8121/aa83bd · Cited by 23
Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide
Zhang, J.-X., Lai, Y.-H., Mi, P., Dai, X., Zhang, R., Zhang, Z., Zhang, S., Zhang, X., Zhang, X., Yang, B., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0560-6 · Cited by 20
Alves-Martínez, P., Atienza‐Navarro, I., Vargas-Soria, M., Carranza-Naval, M. J., Infante‐Garcia, C., Benavente‐Fernández, I., del Marco, À., Lubián‐López, S. P., & García-Alloza, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.908045 · Cited by 22
“3 Caf Treatment Restores Neuron Density and Curvature We also characterized the neuron density and neuritic curvature as a marker of neuron wellbeing, as previously described (Stern et al., 2004; Meyer-Luehmann et al., 2008).”
MethodHunter, J. M., Bowers, W. J., Maarouf, C. L., Mastrangelo, M. A., Daugs, I. D., Kokjohn, T. A., Kalback, W. M., Luehrs, D. C., Valla, J., Beach, T. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110608 · Cited by 22
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 26
Murakami, K., Shimizu, T., & Irie, K. (2011) · Journal of Amino Acids · doi:10.4061/2011/654207 · Cited by 21
“On the other hand, there is increasing evidence that the oligomeric assembly of Aβ could induce memory decline and synaptotoxicity in AD [24], while mature plaques were reported to be nontoxic [25, 26] and to serve as a store of the toxic assembly of Aβ [27].”
BackgroundFractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models
Pirici, D. N., Cauwenberghe, C. V., Broeckhoven, C. V., & Kumar‐Singh, S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.010 · Cited by 19
Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 20
“Pr ressive h aring impairment leads to s cial isolation, and t comorbi ities like frailty, falls, and late-onset depression, ARHL has been linked with cognitive decline and an increased risk of dementia [13].”
BackgroundInflammation on the Mind: Visualizing Immunity in the Central Nervous System
Kang, S. S., & McGavern, D. B. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-93864-4_10 · Cited by 19
“Daily images of these mice revealed that plaques could be detected in a region previously devoid of plaques 24 h earlier (Meyer-Luehmann et al. 2008).”
BackgroundRichards, G. J., Messer, J., Faull, R. L. M., Stadler, H., Wichmann, J., Huguenin, P. N., Bohrmann, B., & Mutel, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.072 · Cited by 20
Error-protein metabolism and ageing
Hipkiss, A. R. (2008) · Biogerontology · doi:10.1007/s10522-008-9188-9 · Cited by 18
“Changes in polypeptide metabolism underpin ageing and many related pathologies (Rattan 2003; Hipkiss 2006; Soskic et al. 2007; Hellstrom-Lindahl et al. 2008; Meyer-Luehmann et al. 2008; Qiu and Folstein 2006).”
Abd‐Elrahman, K. S., Colson, T. L., Sarasija, S., & Ferguson, S. S. G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116388 · Cited by 18
Giannopoulos, P. F., & Praticò, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00002-1 · Cited by 18
Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
Pelkmans, W., Legdeur, N., ten Kate, M., Barkhof, F., Yaqub, M. M., Holstege, H. H., van Berckel, B. N. M., Scheltens, P., van der Flier, W. M., Visser, P. J., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51273 · Cited by 18
“Possibly, as this effect was only observed in abnormal Ab, it might reflect a tissue reactive response to Ab pathology, as previous studies have shown a positive correlation of microglial activation and Ab deposition.(59) Microglial activation in preclinical disease stages has been associated with initially preserved…”
ResultThe Shape of μ—How Morphological Analyses Shape the Study of Microglia
Bosch, L. F. P., & Kierdorf, K. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.942462 · Cited by 23
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
Yao, A. Y., Halloran, P. J., Ge, Y., Singh, N., Zhou, J., Galske, J., He, W., Yan, R., & Hu, X. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-22.2023 · Cited by 17
Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress
Pham, T. N. M., Perumal, N., Manicam, C., Başoğlu, M., Eimer, S., Fuhrmann, D. C., Pietrzik, C. U., Clement, A. M., Körschgen, H., Schepers, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102943 · Cited by 19
Music compensates for altered gene expression in age-related cognitive disorders
Gómez‐Carballa, A., Navarro, L., Pardo‐Seco, J., Bello, X., Pischedda, S., Viz-Lasheras, S., Camino‐Mera, A., Currás-Tuala, M. J., Ferreirós-Vidal, I., Mallah, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48094-5 · Cited by 23
Meyer‐Luehmann, M., Mora, J. R., Mielke, M. L., Spires‐Jones, T. L., de Calignon, A., von Andrian, U. H., & Hyman, B. T. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-22 · Cited by 17
“8%tert-pentylalcohol; 250 mg/kg) by installing a glass window 6 mm in diameter on top of the brain [36-38].”
MethodSelf-citationKong, W., Zhang, J., Mou, X., & Yang, Y. (2014) · Computational and Mathematical Methods in Medicine · doi:10.1155/2014/340758 · Cited by 20
Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
Rembach, A., Ryan, T. M., Roberts, B. R., Doecke, J. D., Wilson, W. J., Watt, A. D., Barnham, K. J., & Masters, C. L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.59 · Cited by 20
Bitencourt, A. L. B., de Campos, R. M., Cline, E. N., Klein, W. L., & Sebollela, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238920 · Cited by 21
“Single-chain variable fragments (scFvs), the smallest antibody fragments containing a complete antigen binding site, are recombinant molecules of ~30 kDa in which the variable domains of both VL and VH chains are engineered into a single polypeptide chain connected by a flexible peptide linker and/or a disulfide bond…”
BackgroundMoelgg, K., Jummun, F., & Humpel, C. (2021) · Biomolecules · doi:10.3390/biom11030434 · Cited by 19
“[17,18] have shown that brain extracts from human AD patients or AD mice can induce the AD plaque pathology.”
Background(2012) · Europe PMC (PubMed Central)
Self-citationP3‐292: Grape seed polyphenolic extract specifically decreases Aβ∗56 in the brains of Tg2576 mice
Liu, P., Kotilinek, L., Kemper, L. J., Wang, J., Zahs, K. R., Ashe, K. H., & Pasinetti, G. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1792 · Cited by 17
Dcf1 Deficiency Attenuates the Role of Activated Microglia During Neuroinflammation
Wang, J., Li, J., Wang, Q., Kong, Y., Zhou, F., Li, Q., Li, W., Sun, Y., Wang, Y., Guan, Y., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00256 · Cited by 19
The multiple mechanisms of amyloid deposition: The role of parkin
Mena, M. A., Rodríguez‐Navarro, J. A., & de Yébenes, J. G. (2009) · Prion · doi:10.4161/pri.3.1.8122 · Cited by 20
Enlargement of Aβ aggregates through chemokine-dependent microglial clustering
Huang, W.-C., Yen, F.-C., Shiao, Y., Shie, F., Chan, J.-L., Yang, C.-N., Sung, Y.-J., Huang, F.-L., & Tsay, H.-J. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.01.001 · Cited by 18
Ni, R., Deán‐Ben, X. L., Kirschenbaum, D. S., Rudin, M., Chen, Z., Crimi, A., Voigt, F. F., Nilsson, K. P. R., Helmchen, F., Nitsch, R. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.25.964064 · Cited by 18
Manipulation of microglial activity as a therapy for Alzheimer s disease
Ling, E. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s342 · Cited by 15
“However, in another experiment using twophoton microscopy, microglia were recruited to newly formed senile plaques within 1-2 days of their appearance without the clearance of these plaques (38).”
MethodKim, N., Choi, J. G., Park, S., Lee, J. K., & Oh, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061644 · Cited by 18
“It has been shown that accumulated Aβ causes synaptic degeneration involved in memory function [28,29].”
BackgroundAmyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
Huang, Y., Hong, X., Shen, J. X., Geng, L.-J., Pan, Y.-H., Ling, W., & Zhao, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02980 · Cited by 16
“The activated signaling pathways in the early stage of AD play a protective role by phagocytosis and degradation of amyloid aggregates (9, 112).”
BackgroundAhmed, S., Yu, J. H., Mockett, B. G., Zhang, H., Abraham, W. C., & Liu, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137316 · Cited by 16
“Earlier research has reported a strong correlation between plaque burden and microglial gene expression, encompassing both proliferation and activation of microglia [70], and NO can modulate microglial activation and migration [71,72].”
BackgroundReview: Cellular repair strategies in Parkinson's disease
Winner, B., Weisenhorn, D. M. V., Lie, D. C., Blümcke, I., & Winkler, J. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608100324 · Cited by 17
Bao, L., Hao, S., Xi, S., Yan, X., Zhang, H., Shen, R., & Gu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc04913k · Cited by 17
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.